Actuate Therapeutics, Inc.

ACTU·NASDAQ·$2.20Share Price as of 11/2·$53MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report10/28/26 8-KCurrent report07/17/26 8-KCurrent report05/22/26 8-KCurrent report05/11/26

Prospectuses and Registrations

424B5Prospectus supplement10/28/26 S-1/ARegistration statement (amended)10/19/26 S-1/ARegistration statement (amended)10/14/26 FWPFree writing prospectus10/08/26 S-1Registration statement (IPO)10/06/26

Proxies

DEFA14AAdditional proxy materials05/06/26 DEF 14ADefinitive proxy04/06/26 DEFA14AAdditional proxy materials04/06/26 DEFA14AAdditional proxy materials04/09/25 DEF 14ADefinitive proxy04/08/25

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction10/30/26 Form 4Insider transaction10/29/26 Form 4Insider transaction08/14/26 Form 4Insider transaction05/22/26

Other

EFFECTRequest for effectiveness10/26/26 DRSDRS06/08/26 ARSAnnual report to shareholders04/09/26 EFFECTRequest for effectiveness09/08/25 CORRESPCorrespondence with the SEC09/04/25